Probiotic and brain health in women with mild depression
This study tests whether taking a daily probiotic supplement can improve mood and cognitive function in women with mild depressive symptoms. If you are eligible, you may contribute to understanding new ways to support mental health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 50 and 64 years old.
- You have mild symptoms of depression, as measured by a standard questionnaire.
- You are willing to take a daily supplement for the study period.
- You have not taken antibiotics, probiotics, or certain supplements recently.
- You do not have certain mental health conditions or take specific psychiatric medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking probiotics can help with mild to moderate depression symptoms. It also looks at how probiotics affect brain activity.
This study tests whether a probiotic supplement called PB-18 can help reduce symptoms of mild to moderate depression. Probiotics are live beneficial bacteria that may affect mood through gut-brain connection.
This study tests whether taking a probiotic supplement can improve mental health. You would take the supplement and have your mood and thinking checked over some weeks.
This trial tests a probiotic called IBNI617 for people with moderate to severe depression who are not currently taking antidepressant medication. It aims to see if this probiotic can help improve mood and depression symptoms.
This trial tests if a probiotic supplement (GynMDD) can boost the effects of supportive therapy for people with mild to moderate depression. If you're not taking antidepressants and have no suicidal thoughts, this may be an option for you.
This trial tests if probiotics can help reduce symptoms of mild to moderate anxiety or depression. It is for people aged 18–60 who are not currently taking most anxiety or depression medications and who have not used them in the last 2 weeks (except for escitalopram).
Hear when a new Cognition Function trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.